SGMT sagimet.com Earnings growth forecast for next year

Corporate emblem and logo of Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences (SGMT) complies with environmental waste disposal regulations, while the dynamic chart on GURU.Markets displays the consensus estimate for net profit growth rates, where the latest parameter is -18.90. Business development relies on partnerships with medical centers to accelerate steatohepatitis therapy. High scalability is ensured by formula patents, guaranteeing global dominance with minimal production costs.

Sagimet (SGMT): Expected net earnings per share growth next year from 02/21/2024 to 11/18/2026

SGMT (Sagimet Biosciences, Inc.): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Initial company analysis:SGMT, sagimet.com
Finished products of Sagimet Biosciences Inc.

The projected profit growth for the coming year allows for an assessment of the business's future value, neutralizing the time lag associated with standard reporting. This metric measures the expected EPS dynamics, accounting for current inflationary risks and operating expenses. By analyzing the consensus estimate of net profit growth rates, an investor can discern the company's market development vector. However, for Sagimet Biosciences (SGMT), geopolitical instability and logistical disruptions could significantly adjust these expectations.

Analysis of competing companies

ASND (Ascendis) - Earnings growth forecast for next year|Earnings growth forecast for next year Madrigal Pharmaceuticals|Earnings growth forecast for next year CORT|Net earnings per share growth forecast for next year RYTM (Rhythm Pharma)|Net earnings per share growth forecast for next year akerotx.com AKRO|Metsera Therapeutics (MTSR) - Expected net earnings per share growth next year|MLTX - Net earnings per share growth forecast for next year|CRNX: Net earnings per share growth forecast for next year|NAMS: Earnings growth forecast for next year|SLNO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Amicus Corp|89bio Pharma (ETNB) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agios.com (AGIO)|Expected earnings per share growth for next year structuretx.com GPCR|Net earnings per share growth forecast for next year MiMedx Group Inc MDXG|Expected earnings per share trend next year RZLT|lexpharma.com - Earnings growth forecast for next year|MBX (MBX Biosciences Inc) - Projected earnings per share growth rate for next year|ALT: Earnings growth forecast for next year|Aardvark Therapeutics Inc - Expected earnings per share trend next year|BIOA (bioagelabs.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year Biomea Fusion (BMEA)|Earnings growth forecast for next year QNCX|Projected earnings per share increase next year GUTS|Earnings growth forecast for next year VTVT (vTv Therapeutics Inc.)|Expected earnings per share trend next year ATPC|Pluristem Therapeutics - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year synlogictx.com SYBX|LPCN: Earnings growth forecast for next year|Matinas BioPharma Holdings, Inc. - Expected earnings per share trend next year|SPRB (Spruce Biosciences Inc.) - Earnings growth forecast for next year|galecto.com (GLTO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year organovo.com ONVO|Radius Health (RDUS) - Expected net earnings per share growth next year